Canada markets close in 39 minutes

Janux Therapeutics, Inc. (JANX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
47.960.00 (0.00%)
As of 03:20PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.48B
Enterprise Value 2.16B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)261.17
Price/Book (mrq)7.20
Enterprise Value/Revenue 267.00
Enterprise Value/EBITDA -30.39

Trading Information

Stock Price History

Beta (5Y Monthly) 4.18
52-Week Change 3205.48%
S&P500 52-Week Change 321.61%
52 Week High 358.69
52 Week Low 35.65
50-Day Moving Average 333.03
200-Day Moving Average 315.78

Share Statistics

Avg Vol (3 month) 3889.11k
Avg Vol (10 day) 31.13M
Shares Outstanding 551.66M
Implied Shares Outstanding 651.66M
Float 818.61M
% Held by Insiders 113.78%
% Held by Institutions 183.29%
Shares Short (Mar 28, 2024) 43.75M
Short Ratio (Mar 28, 2024) 43.69
Short % of Float (Mar 28, 2024) 415.52%
Short % of Shares Outstanding (Mar 28, 2024) 47.27%
Shares Short (prior month Feb 29, 2024) 42.9M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-655.71%

Management Effectiveness

Return on Assets (ttm)-12.25%
Return on Equity (ttm)-17.53%

Income Statement

Revenue (ttm)8.08M
Revenue Per Share (ttm)0.18
Quarterly Revenue Growth (yoy)-13.50%
Gross Profit (ttm)N/A
EBITDA -71.02M
Net Income Avi to Common (ttm)-58.29M
Diluted EPS (ttm)-1.32
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)344.03M
Total Cash Per Share (mrq)6.66
Total Debt (mrq)24.54M
Total Debt/Equity (mrq)7.13%
Current Ratio (mrq)26.80
Book Value Per Share (mrq)7.45

Cash Flow Statement

Operating Cash Flow (ttm)-50.58M
Levered Free Cash Flow (ttm)-29.52M